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Background: Pulmonary vein isolation (PVI) has become an important option for treating patients with
atrial ﬁbrillation (AF). Periesophageal nerve (PEN) injury after PVI causes pyloric spasms and gastric
hypomotility. This study aimed to clarify the impact of PVI on gastric motility and assess the prevalence
of gastric hypomotility after PVI.
Methods: Thirty consecutive patients with AF underwent PVI under luminal esophageal temperature
(LET) monitoring. The 13C-acetate breath test was conducted before and after the procedure for all
patients (PVI group). Gastric emptying was evaluated using the time to peak concentration of 13CO2
(Tmax). This test was also conducted in another 20 patients who underwent catheter ablation procedures
other than PVI (control group).
Results: The number of patients with abnormal Tmax (Z75 min) increased from seven (23%) to 13 (43%)
and from three (15%) to ﬁve (25%) after the procedure in the PVI group and control group, respectively.
The mean Tmax was longer after PVI than before PVI (64714 min vs. 57715 min, p¼0.006), whereas
there was no signiﬁcant difference before and after the procedure in the control group. However, no
signiﬁcant difference in ΔTmax was observed between the two groups (p¼0.27). No patients suffered
from symptomatic gastric hypomotility.
Conclusions: Asymptomatic gastric hypomotility occurred more often after PVI. However, the average
impact of PVI on gastric motility was minimal.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Pulmonary vein isolation (PVI) has become an important option
for treating patients with atrial ﬁbrillation (AF) [1]. However, a few
reports have described esophageal injury after PVI, including the
development of lethal atrioesophageal ﬁstulae. In addition, perieso-
phageal nerve (PEN) injury after PVI may rarely cause pyloric spasms
and gastric hypomotility [2]. These disorders lead to abdominal
distension and discomfort. No quantitative or objective methods have
been published for diagnosing PEN injury after PVI. The 13C-acetate
breath test has been used to diagnose delayed gastric emptying
induced by gastric hypomotility and/or pyloric spasms. This method
is a noninvasive alternative to scintigraphy.
The objectives of this study were to clarify the impact of PVI on
gastric motility, the prevalence of gastric hypomotility after PVI,
and the relationship between de novo esophageal injury and
gastric hypomotility following PVI. The 13C-acetate breath test
and esophagogastroduodenoscopy (EGD) were performed before
and after the procedure to achieve these objectives.
2. Material and methods
2.1. Patient population
Thirty-one consecutive patients with symptomatic paroxysmal or
persistent AF were included in this prospective study. Patients with a
history of PVI, the Maze procedure, gastrostomy, an eating disorder, or
episodes of acute coronary syndrome, emboli, or decompensated
heart failure within 3 months before enrollment were excluded. We
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enrolled 20 patients who underwent ablation procedures other than
PVI as the control group.
All patients provided written informed consent prior to parti-
cipation in this study. The study protocol was approved by the
research ethics board of each institution.
EGD was performed in all patients within 3 months before the
ablation procedure and within 3 days after the procedure. Eso-
phageal injury was deﬁned as a de novo lesion detected on the
anterior wall of the midthoracic esophageal region after PVI that
had not been detected before the procedure.
Administration of rabeprazole (30 mg/day) was scheduled to start
the day after PVI and was re-evaluated on the day of the gastric
emptying test after PVI to avoid worsening any esophageal injury. Oral
medications, other than rabeprazole, that affected gastric peristalsis
were initiated or changed in all patients within a month before the
ablation and in the hospital.
Measurements of the gastroesophageal reﬂux disease symp-
toms scale and the gastrointestinal symptom rating scale were
obtained before and after PVI. These scales are used to evaluate
common symptoms of patients with gastrointestinal digestive
disorders such as reﬂux esophagitis [3,4].
2.2. 13C-acetate breath test
Gastric emptying was evaluated using the 13C-acetate breath test
with a slight modiﬁcation [5–7]. Gastric emptying is conventionally
evaluated using the acetaminophen absorption test or technetium-
99m scintigraphy [8]. However, the acetaminophen absorption test
requires repeated collection of blood samples, and scintigraphy
requires specialized instrumentation. Both examination times are
approximately 4 h. In contrast, the 13C-acetate breath test, which is
an alternative method to the acetaminophen absorption test or
scintigraphy, can be performed at the patient's bedside. A strong
correlation is observed between gastric emptying time measured by
scintigraphy and the time to peak 13CO2 concentration in an expired
breath (Tmax) as well as half-dose recovery time (T1/2) measured by
the 13C acetate breath test [9]. Tmax in patients with functional
dyspepsia is signiﬁcantly delayed compared with that in healthy
controls [9]. Therefore, we chose the 13C-acetate breath test, which
was modiﬁed by not measuring T1/2, as described previously [5,6,10].
The examination time was 90min. 13C-sodium acetate administered
orally with a test meal moves from the stomach and is absorbed by
the intestines, where it is subsequently metabolized to 13CO2, and
ﬁnally expired by the lungs (Fig. 1). If a patient has gastric hypomo-
tility, the duration between swallowing the test meal and the test
meal reaching the intestines is longer than that in normal patients. As
a result, Tmax in a patient with gastric hypomotility is longer than that
in a patient without gastric hypomotility. Therefore, delayed Tmax
reﬂects delayed gastric emptying.
In accordance with previous studies [5,6], we considered
TmaxZ75min to reﬂect abnormal gastric emptying. This duration
has been validated on the basis of a mean and standard deviation
value of 43.9710.3 min and a median value of 70 min in patients
with advanced Parkinson's disease, which is commonly associated
with dyspepsia [7].
Patients undergoing catheter ablation were tested after an over-
night 12-h fast. First, a breath sample was obtained after ingestion of a
liquid test meal (Racol, 200 kcal/200 mL; Otsuka Pharmaceutical Co.,
Ltd., Otsuka, Japan) which contained 100mg of 13C-sodium acetate
(Sigma-Aldrich, St. Louis, MO, USA). The test meal was consumed in
o5 min, and breath samples were collected after 5, 10, 15, 20, 30, 40,
50, 60, 75, and 90min. Patients remained in a seated position
throughout the examination. All breath samples were analyzed using
infrared isotope spectrometry (POC one; Otsuka Electronics Co., Ltd.,
Otsuka, Japan). Gastric emptying was evaluated by the peak time of
13CO2 excretion (Tmax) [5,6]. The 13C-acetate breath test was conducted
early in the morning before catheter ablation and was repeated early
in the morning 1–3 days after catheter ablation.
2.3. Computed tomography (CT)
Cardiac-enhanced CT (CCT) was performed before the procedure
to obtain three-dimensional images of the heart, thoracic vessels,
and esophagus. This was to exclude the presence of a thrombus and
to avoid transesophageal echocardiography, which may increase the
burden in patients with a low CHADS2 score (o2).
2.4. Ablation procedure and monitoring of luminal esophageal
temperature (LET)
All antiarrhythmic drugs were discontinued for at least ﬁve half-
lives before the day of the ablation procedure. Warfarin and dabiga-
tran were discontinued for 5 days and on the day preceding the
ablation procedure, respectively, and were substituted with intrave-
nous unfractionated heparin (15,000 units/day). The electrophysiolo-
gical study and ablation were performed under continuous
dexmedetomidine hydrochloride infusion. We adjusted the dose
between 0.2 and 0.7 μg/kg/h. A deﬂectable quadripolar electrode
catheter was positioned in the coronary sinus. When the baseline
heart rhythm showed AF, sinus rhythm was restored by external
cardioversion. After trans-septal catheterization, intravenous heparin
was administered to maintain an activated clotting time of 250–300 s.
A three-dimensional reconstruction of the LAwas performed using an
electroanatomical mapping system (Carto3™, Biosense Webster, Dia-
mond Bar, CA, USA). The electroanatomical map was integrated with
the CT image (Carto Merge™, Biosense Webster). A 7-Fr ablation
catheter with a 3.5-mm open-irrigated distal tip (Thermocool Navis-
tar™, Biosense Webster) was used for mapping and ablation. An
esophagram was obtained after oral administration of 10 mL of
gastrograﬁn before PVI. After esophagraphy and venography, an LET
monitoring probe (Sensi Therm; St. Jude Medical, St. Paul, MN, USA)
with three metal thermocouple electrodes (5-mm distance) was
placed within the esophagus under ﬂuoroscopic guidance, directly
posterior to the LA at a level covering the antra of the left PVs. The
ipsilateral left and right PVs were encircled at the antrum in a single
lesion line by circumferential PVI using a dragging technique. The
end-point of PVI was deﬁned as the elimination of all PV potentials on
the circular mapping catheter during sinus rhythm, while an exit
block was conﬁrmed by pacing from inside the PV using the circular
mapping catheter. If PV potentials continued after creating the
circumferential lesion, additional radiofrequency applications were
delivered to the carina between the PVs. The radiofrequency generator
(Biosense Webster) was set at 30–35W and 42 1C. The power and
duration of the radiofrequency applications were limited to 25W and
30 s, respectively, on the posterior wall adjacent to the esophagus
according to the esophagram or the merged CT image. Ablation
energy was stopped when the LET reached 40 1C. After a period of
waiting until the LET decreased to r39 1C, RF was resumed at 15–
20W. If the lower and shorter applications did not create a lesion,
another part of the linear lesion was dragged further from the
esophagus.
2.5. Statistical analysis
Continuous variables are reported as means7standard deviations
and discrete variables as percentages. Continuous variables were
compared with the t-test. Categorical variables were compared using
the chi-square test. Correlations were tested with the nonparametric
Spearman's rank correlation test. All statistical analyses were carried
out using SPSS 21 for Windows software (SPSS Inc., Chicago, IL, USA).
p-Values of o0.05 were considered statistically signiﬁcant.
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3. Results
3.1. Patient characteristics
After obtaining informed consent, a thrombus was detected in the
LAA of one AF patient by CCT; this patient was excluded from the
study. Thirty out of 31 patients with AF and all 20 patients in the
control group completed the required procedures and were analyzed.
No patient suffered from stroke or hemopericardium requiring
pericardiocentesis. The baseline characteristics of both the PVI and
control groups are shown in Table 1. No signiﬁcant differences were
observed in baseline characteristics between groups, except history of
heart failure and stroke. The mean CHADS2 score was 0.6770.76 in
the AF group, with a maximum score of 2.0.
3.2. The 13C-acetate breath test
The number of patients with abnormal Tmax (Z75 min) increased
from seven (23%) to 13 (43%) after the procedure in the PVI group
(Fig. 2A). The seven patients with abnormal Tmax before PVI also had
abnormal Tmax after PVI. No signiﬁcant differences were observed
between the histories of these seven patients and those of the other
patients (Table 2). The number of patients with abnormal Tmax
increased from three (15%) to ﬁve (25%) after the procedure in the
control group (Fig. 2B). The mean Tmax was longer after PVI than
before PVI (64714min vs. 57715min, p¼0.006; Fig. 2C). On the
other hand, the mean Tmax in the control group was not signiﬁcantly
different after the procedure (56716min vs. 53716min, p¼0.35;
Fig. 2D).
Proton pump inhibitor (PPI) administration was initiated between
the ﬁrst and second 13C-acetate breath test in ﬁve patients with AF.
The mean Tmax was signiﬁcantly longer after PVI than before PVI
when the effects of the PPI on gastric emptying were considered, even
after excluding these ﬁve patients (58716min vs. 64715 min,
p¼0.039).
The mean difference between Tmax before and after the procedure
(ΔTmax) was 7.7 min in the AF group and 3.3 min in the control group
(p¼0.27).
No signiﬁcant difference was observed in the quantity of the
radiofrequency energy applied to the left side of the posterior wall of
the LA or the number of points of LET 439 1C between the groups
(normal Tmax to normal Tmax vs. normal Tmax to abnormal Tmax;
Table 2). In addition, there was no correlation between ΔTmax and the
quantity of radiofrequency energy applied to the left side of the
posterior wall of the LA (p¼0.82) or the number of points of LET
439 1C (p¼0.30).
3.3. EGD ﬁndings and clinical symptoms
Reﬂux esophagitis and hernia were detected in seven (23%) and
nine (30%) patients, respectively, before PV (Table 3). No patients had
food residue in the stomach or esophageal mucous membrane lesions
before the procedure. Furthermore, no patient suffered from digestive
Fig. 1. Schematic process of metabolism and respiratory excretion of 13C. (A) 13C-sodium acetate administered orally with a test meal moves from the stomach and is
absorbed from the digestive tract, where it is subsequently metabolized to 13CO2, and ﬁnally expired by the lungs. (B) 13CO2 gradually increases in association with
metabolism. It reaches the peak of excretion (Tmax) and then decreases. Tmax, time to peak concentration of 13CO2 in expired breath.
Table 1
Baseline characteristics of patients in the AF and control groups.
AF group Control group
Age, years 61.878.3 61.8713.4
Sex, M/F (n) 21/9 12/8
Paroxysmal/persistent AF (n) 26/4 –
LVEF, % 6279 62710
Left atrial diameter, mm 4077 3875
Body height, cm 16679 16279
Body weight, kg 68713 61711
BMI, kg/cm2 24.674.1 23.473.2
Diabetes mellitus, n 4 (13%) 3 (15%)
Hypertension, n 11 (37%) 7 (35%)
Congestive heart failure, n 2 (7%) 0 (0%)
Stroke history, n 3 (10%) 0 (0%)
CHADS2 score, n 0.6770.76 0.5570.69
Peptic ulcer history, n 0 (0%) 0 (0%)
PVC, n – 6
PSVT, n – 8
AT/AFL, n – 6
Data are expressed as means7SDs or n (%).
AF, atrial ﬁbrillation; AT, atrial tachycardia; AFL, atrial ﬂutter; BMI, body mass
index; PSVT, paroxysmal supraventricular tachycardia; PVC, premature ventricular
contraction; LVEF, left ventricular ejection fraction.
The left atrial diameter is measured in the parasternal view.
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symptoms such as nausea, vomiting, bloating, epigastric pain, or
dyspepsia after the procedure. Three patients exhibited erosion of
the esophagus (Fig. 3), but only one of these patients exhibited
prolonged Tmax. Food residue in the stomach was detected in another
three patients, but only one had an abnormal Tmax after PVI. Of the
other 24 patients with no EGD ﬁndings, 13 had an abnormal Tmax.
Furthermore, no patient developed a symptomatic PEN injury after
PVI during their hospital stay.
4. Discussion
4.1. Major ﬁndings
This study demonstrated signiﬁcantly, although only slightly,
prolonged gastric emptying after PVI compared with that before the
procedure. Asymptomatic gastric hypomotility was demonstrated
more frequently after PVI. These ﬁndings may represent the inhibitory
effects on PEN. However, the average impact of PVI on gastric motility
under monitoring of the LET was small. The vagus nerve modulates
the secretion of gastric acid and gastric peristalsis. In the thoracic
cavity, the left vagus nerve forms the mesh-like anterior esophageal
plexus after traveling behind the left pulmonary hilum and enters the
abdomen through the esophageal diaphragmatic opening (Fig. 4).
Inside the abdominal cavity, the anterior vagus nerve from the
esophageal plexus lies extremely close to the outer muscle of the
abdominal esophagus and divides near the esophageal end of the
lesser curvature into the gastric and pyloric branches. Therefore,
the anterior vagal nerve is responsible for coordinated relaxation of
the pyloric sphincter and gastric peristalsis during gastric emptying
[11]. Because radiofrequency energy may injure the esophagus, it is
possible that the esophageal nerve plexus situated between the left
atrium and esophagus can also be injured. However, if the radio-
frequency energy injures any part of the plexus, although rare, PEN
injury may occur. Because the plexus surrounds the entire circumfer-
ence of the esophagus, the nerve rarely becomes completely blocked.
Kuwahara et al. recently reported the characteristics of PEN
injuries that complicate PVI [12]. They reported that patients with
PEN injuries were deﬁned as those with symptoms of delayed
gastric emptying, such as nausea, vomiting, postprandial fullness,
and bloating, associated with gastric hypomotility as assessed by
gastrointestinal ﬂuoroscopy. Eleven of 3538 patients (0.3%) were
diagnosed with a periesophageal vagus nerve injury. They only
described patients with severe symptoms. The average impact of
RF energy on PEN and the prevalence of asymptomatic or slight
PEN injury were previously unknown. This study demonstrates the
minimal average impact and shows a very low incidence of severe
PEN injury.
Using electrogastrography, Lo et al. showed that the perieso-
phageal vagus plexus may be injured after PVI [13]. Similar to the
Fig. 2. Results of the 13C-acetate breath tests before and after the ablation procedure. (A) Number of patients with abnormal Tmax in the PVI group. (B) Number of patients
with abnormal Tmax in control group. White parts represent the patients who had abnormal Tmax before the procedure. Black parts represent the patients who have new
abnormal Tmax after the procedure. (C, D) The longitudinal axis represents the peak time of 13CO2 excretion (Tmax) measured by the 13C-acetate breath test. Each patient's Tmax
results from before and after the procedure are linked by a line. (C) Mean Tmax in all patients before and after PVI. (D) Mean Tmax in all patients before and after the procedure
in the control group. Tmax, time to peak concentration of 13CO2 in an expired breath; PVI, pulmonary vein isolation.
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13C-acetate breath test, electrogastrography is noninvasive and
may be a surrogate measure of gastric emptying.
We observed a discrepancy between the presence of food
residue as detected during EGD and abnormal Tmax in the gastric
emptying test.
One reason is that we used a liquid meal for the test; therefore, the
results were representative of liquid gastric emptying. In contrast, food
residue indicated a delay in gastric emptying of solid material. We
consider that this difference may lead to conﬂicting results. The
secretion of pepsin is evoked by vagus nerve stimulation. Decomposi-
tion in the stomach was probably affected by RF energy through the
PEN injury. The additive effect may result in the formation of solid
residue, even when the PEN is slightly affected by RF energy. When a
patient complains of gastroparesis-like symptoms but has normal
ﬁndings of EGD after AF ablation, the 13C-acetate breath test may be
helpful to diagnose the possible periesophageal vagal nerve injury.
In addition to the direct effects of RF energy, mental stress,
fatigue, and other factors may also have a considerable inﬂuence.
In the control group, some patients exhibited delayed Tmax after
the procedure compared with that before the procedure. This
ﬁnding indicates that not only a direct effect of RF energy but also
mental or other stress can inﬂuence gastric emptying after the
procedure, including PVI.
Dexmedetomidine has previously been shown to affect gastric
emptying [14,15]. Some reports also indicated that PPIs inﬂuence
Tmax [16–18]. Takahashi et al. reported that rabeprazole may delay
Tmax to a greater extent than H2 receptor antagonists, although
this difference was not signiﬁcant. Rabeprazole suppresses gastric
emptying of liquid nutrients after the ingestion of a meal. Even
after exclusion of patients for whom PPI administration was
initiated between the ﬁrst and second 13C-acetate breath tests,
the mean Tmax was signiﬁcantly longer after PVI than before PVI.
Iirola et al. showed that dexmedetomidine administered at the
upper limit of the recommended dose (0.7 μg/kg/h) inhibited gastric
emptying, where as Memis et al. reported that doses administered at
the lower limit did not affect gastric emptying. These reports
evaluated gastric emptying several minutes after intravenous
injection. In the present study, we used a low to medium dose of
dexmedetomidine and evaluated the effect 1–3 days after the
intravenous injection. Because the half-life of dexmedetomidine is
extremely short (2 h), we predicted that it would barely inﬂuence
gastric emptying in our study.
Before PVI, reﬂux esophagitis and hernia were detected in 23% and
30% of patients, respectively. As already described in Table 2, PPI was
administered at the time of enrollment in 20% patients with AF and
may potentially have led to a risk of symptomatic delayed gastric
emptying and esophageal injury after PVI. The possibility that the PPI
may have inﬂuenced gastric emptying in some of the patients with AF
at baseline also cannot be ruled out.
Low air inﬁltration occurred in some patients during the proce-
dure. However, this was transient and patients recovered by decreas-
ing sedation dose. Adaptive servo ventilator or airway devices were
not used, but it cannot be denied that these patients might have
potential sleep apnea syndrome (SAS).
Table 2
Clinical characteristics and gastric emptying in the AF group patients.
Normal Tmax before PVI Abnormal Tmax before PVI p Value Normal Tmax before PVI p Value
Normal Tmax after PVI Abnormal Tmax after PVI
(N¼23) (N¼7) (N¼17) (N¼6)
Age, years 61.078.9 64.775.7 0.49 60.379.0 62.879.2 0.55
Sex, M/F (n) 18/5 3/4 0.07 13/4 5/1 0.82
Paroxysmal/persistent AF 19/4 7/0 0.24 14/3 5/1 0.57
LVEF, % 63710 6175 0.58 6479 58713 0.97
Left atrial diameter, mm 4078 4078 0.98 4178 3676 0.23
Body height, cm 16779 16078 0.07 16678 170710 0.51
Body weight, kg 68714 67714 0.94 70714 63711 0.26
BMI, kg/cm2 24.374.3 25.673.3 0.18 25.274.3 21.973.7 0.06
Total RF energy for PW, J 38,459711729 35,643720297 0.44 35,398715517 40,72078068 0.26
Procedure time, min 167738 169732 0.88 165738 171742 0.83
Radiofrequency time, min 82727 81719 0.93 82728 80727 0.67
Point of LET439 1C, n 4.573.7 7.877.1 0.20 4.573.6 4.774.1 0.94
HPIGG (positive/negative) 9/14 3/3 0.63 5/9 4/2 0.43
FSSG
Pre, pt 3.974.3 6.276.7 0.68 4.874.8 1.771.2 0.12
Post, pt 5.077.0 4.275.9 0.65 6.178.0 2.271.6 0.26
GSRS
Pre, pt 22.976.1 24.078.2 0.98 23.976.5 20.574.7 0.21
Post, pt 23.577.8 26.979.9 0.51 24.578.6 20.774.6 0.39
Data are expressed as means7SDs or n (%).
Tmax, time to peak concentration of 13CO2 in an expired breath; normal baseline, patients with normal Tmax before pulmonary vein isolation (PVI); abnormal baseline,
patients with abnormal Tmax before PVI; AF, atrial ﬁbrillation; BMI, body mass index; HPIGG, Helicobacter pylori IgG; PW, posterior wall; LVEF, left ventricular ejection
fraction; RF, radiofrequency.
We deﬁned Tmax of equal to or longer than 75 min as abnormal Tmax.
Table 3
Gastrointestinal ﬁndings in the AF and control groups.
AF group Control group
Pre-PVI Post-PVI Pre-PVI Post-PVI
Tmax, min 57715 64714 53716 56716
FSSG, pt 4.575.0 4.976.7 6.375.4 4.675.4
GSRS, pt 23.276.5 24.378.3 28.3710.7 26.4710.6
GERD, n (%) 7/30 (23%) 7/30(23%) – –
Hiatal hernia, n (%) 9/30 (33%) 8/30 (27%) – –
Residue of food, n (%) 0 3/30 (10%) – –
Erosion of esophagus, n (%) 0 3/30 (10%) – –
PPI, n (%) 5/30 (17%) 0/20
Data are expressed as means7SDs or n (%).
Tmax, time to peak concentration of 13CO2 in expired breath; PVI, pulmonary vein
isolation; FSSG, frequency scale for symptoms of gastroesophageal reﬂux disease;
GERD, gastroesophageal reﬂux disease; GSRS, gastrointestinal symptom rating
scale; HPIGG, Helicobacter pylori immunoglobulin G; PPI, administration of a proton
pump inhibitor at the time of enrollment.
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Respiratory failure is associated with the presence of reﬂux
esophagitis [19]. Continuous positive airway pressure (CPAP)
reduces reﬂux esophagitis with respiratory failure [20]. Respira-
tory support device such as CPAP may preserve gastric motility.
4.2. Study limitations
This study had some limitations. First, we investigated a small
group of patients only during the acute phase. Therefore, it is nec-
essary to evaluate a larger number of patients from multiple
centers with a longer follow-up for further clariﬁcation of the
clinical implications.
Second, because we used the modiﬁed 13C acetate breath test, we
measured excretion only up to 90 min. In patients with peak times of
13CO2 excretion 490min, Tmax may be considered as 90 min. In our
study, two patients out of 30 had a Tmax of 90 min before ablation. In
both patients, this was 75 min after ablation. If patients have a greater
degree of gastric hypomotility than this, we may overestimate the
impact of RF energy. Likewise, another two patients had a time of
90 min after ablation. One of them marked 60min before ablation
and the other 75 min. If they had more gastric hypomotility, we may
underestimate the impact of RF energy.
Third, the precise number of patients who underwent transmural
ablation in this study remains unknown. The use of a contact force
catheter could have facilitated more reliable investigations.
Fourth, we did not evaluate SAS in the present study. SAS is not
only related to AF, but also related to reﬂux esophagitis. Some papers
have inferred that SAS is related to reﬂux esophagitis [19]. However,
another paper has found that SAS is not related to reﬂux esophagitis
[21]. In this paper, Ju et al. reported that poor subjective sleep and
depressive symptoms are associated with the presence of reﬂux
esophagitis with no association between SAS, BMI and reﬂux esop-
hagitis.
5. Conclusions
Asymptomatic gastric hypomotility was demonstrated to occur
more frequently after PVI. However, the average impact of PVI on
gastric motility under monitoring of the LET was minimal.
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